Why the study?
Does perforin deficiency prevent acute rejection of vascularized heart allografts in mice?
Does perforin deficiency prevent acute rejection of vascularized heart allografts in mice?
Perforin is not essential for acute rejection of fully mismatched heart allografts but plays a role in the rejection of single MHC class I mismatched grafts.
Perforin deficiency fails to prevent acute rejection of fully mismatched murine heart grafts; leaves open its role in MHC class I mismatched allograft survival.
To study the role of perforin in cell-mediated graft rejection, vascularized hearts were grafted to perforin-deficient C57BL/6 and control C57BL/6 recipient mice. Fully allogeneic heart grafts (BALB/c) were acutely rejected by both recipients within 6 days. Peritoneal exudate lymphocytes from control mice but not from perforin-deficient mice exhibit a strong alloreactive cytotoxic activity in vitro. Histological analysis of the rejected tissues demonstrated extensive mononuclear cell infiltrates in both recipients. Flow cytometry analysis and immunohistology of graft-infiltrating cells showed similar proportions of lymphocyte subsets (CD8 >> CD4). Collectively, these data indicate that perforin is not essential in the cell-mediated acute rejection of a fully mismatched heart allograft. However, perforin-dependent effector mechanisms appeared to be limiting in the T cell-mediated rejection of heart allografts differing only at a single major histocompatibility complex class I antigen (bm1), because these grafts survived longer (mean 87.8 days) in perforin-deficient than in control mice (mean 31.5 days).
No takes yet. Share an insight, caveat, or question.
Schulz et al. (1995) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: